Levine James E.
Chief Financial Officer
2 companies
Insider Signal Score
31
WeakTrades Analyzed
5
12M Win Rate
20.0%
Avg 3M Return
-11.8%
Avg 12M Return
-36.8%
Levine James E. serves as a Chief Financial Officer at CRDF and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 11 buys and 0 sells. Those positions are worth an estimated $172K at current prices.
Historically, Levine James E.'s trades have earned a below-average insider score of 31/100 across 5 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -36.8%.
The biggest single holding is CDTX (~$101K) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 80,000 shares.
Holdings by Company
Transaction History
Showing 5 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | CRDF Cardiff Oncology, Inc. | Chief Financial Officer | Buy | 7,716 | $4.76 | $36,725.50 | +4.1% | -15.6% | -44.3% | |
| Sep 16, 2022 | CRDF Cardiff Oncology, Inc. | Chief Financial Officer | Buy | 30,000 | $1.56 | $46,710.00 | +100.0% | -11.4% | +9.5% | |
| Sep 10, 2021 | CRDF Cardiff Oncology, Inc. | Chief Financial Officer | Buy | 30,000 | $6.47 | $194,000.00 | +50.0% | -8.3% | -54.0% | |
| Nov 10, 2020 | Chief Financial Officer | Buy | 50,000 | $2.01 | $100,720.00 | New | - | - | ||
| Sep 24, 2019 | Chief Financial Officer | Buy | 30,000 | $1.91 | $57,240.00 | +17.1% | - | - |